Literature DB >> 7127662

Metabolism of high doses of cyclophosphamide.

R A Milsted, M Jarman.   

Abstract

The excretion of cyclophosphamide and the enzymatically derived metabolites 4-ketocyclophosphamide and carboxyphosphamide has been measured in four patients after the administration of cyclophosphamide (5 g). At this dose the enzymes responsible for the biotransformation and detoxification of cyclophosphamide are not saturated. In two patients the metabolite profile was unaffected by a previous high dose of cyclophosphamide and in one patient a small primary dose did not alter metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127662     DOI: 10.1007/bf00254056

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  12 in total

1.  The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.

Authors:  H T Mouridsen; O Faber; L Skovsted
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-08

2.  Evidence for an aldehyde possessing alkylating activity as the primary metabolite of cyclophosphamide.

Authors:  N E Sladek
Journal:  Cancer Res       Date:  1973-04       Impact factor: 12.701

3.  Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice.

Authors:  J L Millar; T J McElwain
Journal:  Antibiot Chemother (1971)       Date:  1978

4.  Application of deuterium labelling mass spectrometry in a study of the metabolism of the enantiomers of cyclophosphamide.

Authors:  P J Cox; P B Farmer; A B Foster; L J Griggs; M Jarman; R Kinas; K Pankiewicz; W J Stec
Journal:  Biomed Mass Spectrom       Date:  1977-12

5.  The enzymatic basis of the selective action of cyclophosphamide.

Authors:  P J Cox; B J Phillips; P Thomas
Journal:  Cancer Res       Date:  1975-12       Impact factor: 12.701

6.  Synthesis of deuterium-labeled analogs of cyclophosphamide and its metabolites.

Authors:  L J Griggs; M Jarman
Journal:  J Med Chem       Date:  1975-11       Impact factor: 7.446

7.  Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.

Authors:  M Jarman; R A Milsted; J F Smyth; R W Kinas; K Pankiewicz; W J Stec
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

8.  Pharmacokinetics of cyclophosphamide in man.

Authors:  J L Cohen; J Y Jao; W J Jusko
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

9.  Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.

Authors:  J L Millar; B N Hudspith; N M Blackett
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

10.  Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.

Authors:  T J McElwain; D W Hedley; G Burton; H M Clink; M Y Gordon; M Jarman; C A Juttner; J L Millar; R A Milsted; G Prentice; I E Smith; D Spence; M Woods
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

View more
  4 in total

1.  Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Authors:  Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-06-20       Impact factor: 3.015

2.  Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma.

Authors:  P M Wilkinson; P A O'Neill; N Thatcher; S B Lucas
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  Milly E de Jonge; Alwin D R Huitema; Sjoerd Rodenhuis; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

4.  The Protective Effects of Sesamin against Cyclophosphamide-Induced Nephrotoxicity through Modulation of Oxidative Stress, Inflammatory-Cytokines and Apoptosis in Rats.

Authors:  Saeed Alshahrani; Hani M Ali Thubab; Abdulrahman M Ali Zaeri; Tarique Anwer; Rayan A Ahmed; Abdulmajeed M Jali; Marwa Qadri; Yousra Nomier; Sivakumar S Moni; Mohammad F Alam
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.